Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

RoosterBio and MineBio team up to expand MSC solutions access in China

 April 8, 2026

Pharmaceutical Business Review

MineBio will supply RoosterBio’s complete platform of products, having already obtained import clearance.

M&A / DealsRead full story

Post navigation

Halozyme and Vertex sign deal for Hypercon technology →
← EU invests 30m to fight antimicrobial resistance

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com